Apply to trial NCT06207370

A few quick questions so the study team can decide if you might be a fit.

RecruitingPhase 2Drug trial

Oral Tafenoquine Plus Standard of Care Versus Placebo Plus Standard of Care for Babesiosis

This study is a double-blind, randomized, multisite, placebo-controlled trial comparing the safety and efficacy of TQ versus placebo in patients hospitalized for babesiosis with low risk for relapsing disease who will also be administered a standard-of-care antimicrobial regimen (A/A) that is recommended in the 2020 IDSA guideline on the diagnosis and management of babesiosis.

How this works

Answer a few questions
About 5 to 10 minutes. Skip-friendly where possible.
We connect you with the study team
When a site picks up your application, we introduce you to their team directly — with you on the thread.
The team reaches out to schedule screening
Usually within a few business days, via the contact you give.

EmailWe save your progress under this email and copy you when we connect you with the study team.

I agree that Hipa.ai may share my application — my name, contact details, and my answers, including health information — with the official study team for this trial so they can review my responses and contact me.

By continuing, you agree to our terms of service.

Oral Tafenoquine Plus Standard of Care Versus Placebo Plus Standard of Care for Babesiosis

How this works

Answer a few questions

We connect you with the study team

The team reaches out to schedule screening